Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleExperimental Studies

Unravelling the Antiproliferative Activity of 1,2,5-oxadiazole Derivatives

DANIEL EHRSAM, FABIOLA PORTA, MATTEO MORI, HENRIETTE E. MEYER ZU SCHWABEDISSEN, LISA DALLA VIA, AÌDA NELLY GARCIA-ARGAEZ, LIVIA BASILE, FIORELLA MENEGHETTI, STEFANIA VILLA and ARIANNA GELAIN
Anticancer Research July 2019, 39 (7) 3453-3461; DOI: https://doi.org/10.21873/anticanres.13491
DANIEL EHRSAM
1Biopharmacy, Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
FABIOLA PORTA
1Biopharmacy, Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MATTEO MORI
2Department of Pharmaceutical Sciences, University of Milan, Milan, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
HENRIETTE E. MEYER ZU SCHWABEDISSEN
1Biopharmacy, Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
LISA DALLA VIA
3Department of Pharmaceutical and Pharmacological Sciences, University of Padua, Padua, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
AÌDA NELLY GARCIA-ARGAEZ
3Department of Pharmaceutical and Pharmacological Sciences, University of Padua, Padua, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
LIVIA BASILE
4Department of Drug Sciences, Section of Medicinal Chemistry, University of Catania, Catania, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
FIORELLA MENEGHETTI
2Department of Pharmaceutical Sciences, University of Milan, Milan, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
STEFANIA VILLA
2Department of Pharmaceutical Sciences, University of Milan, Milan, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: stefania.villa{at}unimi.it
ARIANNA GELAIN
2Department of Pharmaceutical Sciences, University of Milan, Milan, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

Aim: To develop several new derivatives aimed to complete the studies concerning the antiproliferative profile of the oxadiazole derivative MD77. Materials and Methods: The substitution pattern around the phenyl rings of this compound was analyzed through the synthesis of positional isomers and of analogues bearing different substituents at the para positions (2-12). Results: The results of the antiproliferative activity of these derivatives versus HCT-116 and HeLa cancer cell lines shed light on the effects of the presence, nature and position of such substituents. Notably, derivative 4, a regioisomer of 1 in which the substituents at the para positions of the phenyl rings were inverted, showed the best antiproliferative profile, exhibiting a significant activity also against MCF7 and MDA-MB 468 cancer cell lines. Conclusion: Preliminary results showed the ability of compound 4 to reduce the viability of cancer cells by counteracting human recombinant topoisomerase II α relaxation activity.

  • Furazane
  • cytotoxicity
  • topoisomerase II
  • HCT-116
  • HeLa
  • MCF-7
  • MDA-MB 468
  • Received March 12, 2019.
  • Revision received April 29, 2019.
  • Accepted May 2, 2019.
  • Copyright© 2019, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved
View Full Text
PreviousNext
Back to top

In this issue

Anticancer Research
Vol. 39, Issue 7
July 2019
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Unravelling the Antiproliferative Activity of 1,2,5-oxadiazole Derivatives
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
3 + 1 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Unravelling the Antiproliferative Activity of 1,2,5-oxadiazole Derivatives
DANIEL EHRSAM, FABIOLA PORTA, MATTEO MORI, HENRIETTE E. MEYER ZU SCHWABEDISSEN, LISA DALLA VIA, AÌDA NELLY GARCIA-ARGAEZ, LIVIA BASILE, FIORELLA MENEGHETTI, STEFANIA VILLA, ARIANNA GELAIN
Anticancer Research Jul 2019, 39 (7) 3453-3461; DOI: 10.21873/anticanres.13491

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Unravelling the Antiproliferative Activity of 1,2,5-oxadiazole Derivatives
DANIEL EHRSAM, FABIOLA PORTA, MATTEO MORI, HENRIETTE E. MEYER ZU SCHWABEDISSEN, LISA DALLA VIA, AÌDA NELLY GARCIA-ARGAEZ, LIVIA BASILE, FIORELLA MENEGHETTI, STEFANIA VILLA, ARIANNA GELAIN
Anticancer Research Jul 2019, 39 (7) 3453-3461; DOI: 10.21873/anticanres.13491
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results and Discussion
    • Conclusion
    • Acknowledgements
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Protopanaxadiol Induces Apoptosis in NPC/HK1 Human Nasopharyngeal Carcinoma Cells via the Fas/Caspase-8 Signaling Pathway
  • Self-differentiated Dendritic Cells Presenting NY-ESO-1 Prime Cytotoxic T Cells for the Treatment of Multiple Myeloma
  • Adenylate Kinase 2 Promotes Tumor Progression in Small-cell Lung Cancer via PI3K/AKT/mTOR Signaling
Show more Experimental Studies

Keywords

  • Furazane
  • cytotoxicity
  • topoisomerase II
  • HCT-116
  • HeLa
  • MCF-7
  • MDA-MB 468
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire